文献速递脑血管病

卒中侧别未改变HERMES荟萃分析中7项试验的结局

Stroke Laterality Did Not Modify Outcomes in the HERMES Meta-Analysis of Individual Patient Data of 7 Trials.
PubMed 文献 · Stroke · 2019-07-05

该研究基于HERMES协作的7项随机试验个体患者数据,纳入1737例前循环缺血性卒中患者,比较血管内取栓与标准治疗。结果显示,90天改良Rankin量表功能结局的治疗获益未受卒中侧别影响,左右半球卒中在功能独立、梗死体积和死亡率上均无显著差异。

要点

  • 卒中侧别不是预后因素,也不改变血管内治疗的效果。
  • 左侧半球卒中基线NIHSS评分(中位数20)显著高于右侧(16)。
  • 左右半球卒中的90天功能结局、梗死体积及死亡率均无显著差异。

核心结论

  • 在近期血管内取栓试验中,卒中侧别不是预后因素,也未改变治疗效应。

研究设计与样本

  • 研究为HERMES协作的个体患者数据荟萃分析,纳入7项随机试验,比较血管内取栓(主要使用支架取栓器)与标准治疗。
  • 共纳入1737例前循环缺血性卒中患者,其中右侧半球卒中871例,左侧半球卒中866例。

主要发现

  • 左侧半球卒中基线NIHSS评分中位数20,显著高于右侧的16(P<0.001)。
  • 90天改良Rankin量表移位分析的血管内治疗获益未受卒中侧别影响。
  • 右侧与左侧半球卒中的90天功能结局(mRS≤2:40.7% [95% CI, 37.4%-44.1%] vs 37.6% [95% CI, 37.4%-44.1%];P=0.19)无显著差异。
  • 右侧与左侧半球卒中的最终梗死体积中位数(45 vs 39.5 mL,P=0.51)和90天死亡率(15.1% vs 16.8%,P=0.31)均无显著差异。

关键数值与推荐

  • 90天功能结局良好(mRS≤2)比例:右侧半球40.7%(95% CI 37.4%-44.1%),左侧半球37.6%(95% CI 37.4%-44.1%),P=0.19。
  • 最终梗死体积中位数:右侧45 mL,左侧39.5 mL,P=0.51。
  • 90天死亡率:右侧15.1%,左侧16.8%,P=0.31。

临床怎么用

  • 临床决策中无需因卒中侧别而改变血管内取栓的治疗选择或预后判断。
  • 左侧半球卒中患者基线神经功能缺损可能更重,但治疗获益与右侧半球相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- There is contradictory evidence on the impact of the stroke side (hemisphere) on outcomes. We investigated any effect modification by laterality on stroke patients' outcomes in recent endovascular trials. Methods- Individual patient-level data were combined in this meta-analysis of all patients included in randomized trials comparing endovascular thrombectomy predominantly done with stent retrievers with standard care in anterior circulation ischemic patients with stroke (HERMES [Highly Effective Reperfusion Using Multiple Endovascular Devices] Collaboration). We stratified the 90-day functional outcome assessed by ordinal analysis of the modified Rankin Scale according to the stroke side of patients treated with endovascular therapy versus standard care, adjusted for important prognostic variables. Results- The meta-analysis included 1737 patients (871 right hemispheric strokes and 866 left hemispheric) from 7 trials. Baseline median National Institutes of Health Stroke Scale scores were significantly higher in left (20) versus right (16) hemispheric strokes (P<0.001). Other clinical and radiological baseline characteristics were similar. The beneficial response to endovascular therapy assessed by 90-day modified Rankin Scale shift was not modified by the side of the stroke. There were no significant differences between right and left hemispheric stroke in the 90-day functional outcome (modified Rankin Scale score ≤2; 40.7% [95% CI, 37.4%-44.1%] versus 37.6% [95% CI, 37.4%-44.1%]; P=0.19), median final infarct volumes (45 versus 39.5 mL, P=0.51), nor 90-day mortality (15.1% vs 16.8%, P=0.31). Conclusions- Stroke side was not a prognostic factor and did not modify the treatment effect among patients treated in the endovascular or control groups in recent endovascular thrombectomy trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Almekhlafi MA, Hill MD, Roos YM, et al. Stroke Laterality Did Not Modify Outcomes in the HERMES Meta-Analysis of Individual Patient Data of 7 Trials. Stroke. 2019. PMID: 31272328. doi:10.1161/STROKEAHA.118.023102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。